9 февр. 2012 г.

MAKO Surgical Corp. Showcases MAKOplasty® Total Hip Arthroplasty at American Academy of Orthopaedic Surgeons 2012 Annual Meeting

MAKO Surgical Corp. (NASDAQ: MAKO), a leader in robotic arm assisted partial knee arthroplasty worldwide, today announced the MAKOplasty® Total Hip Arthroplasty (THA) application will be featured at the American Academy of Orthopaedic Surgeons 2012 Annual Meeting (AAOS) being held on February 7-11, 2012 at the Moscone Center in San Francisco, California.

MAKOplasty® THA is the newest application for MAKO's RIO® Robotic Arm Interactive Orthopedic System. The RIO® system will be on exhibit at MAKO's AAOS Annual Meeting Booth #2353. During the meeting, experienced MAKOplasty® orthopedic surgeons will give presentations and hands-on demonstrations of the MAKOplasty® THA application.

"There is clearly a need for precision and accuracy in total hip replacement. We believe the RIO® system, which enables surgeons to achieve consistently reproducible precision for the individual patient, along with our MAKOplasty® THA, are key drivers in leading our growing presence in orthopedic surgery," said Maurice R. Ferrė, M.D., president and CEO of MAKO.

MAKOplasty® THA builds upon MAKOplasty® Partial Knee Resurfacing's proven benefits for patients with early to mid-stage osteoarthritis of the knee. To date, nearly 13,000 patients have benefited from MAKOplasty® partial knee and total hip procedures. In 2012, MAKO anticipates to perform 11,000 to 13,000 MAKOplasty® procedures.

MAKOplasty® THA was introduced in 2011 and is designed to support a surgeon's ability to more accurately align and position a hip implant relative to the specific needs of a patient. It provides a surgeon with a pre-operative 3-D reconstruction of a patient's hip that is used to develop a patient-specific surgical plan. The surgeon then uses the RIO® robotic arm during the procedure to prepare the joint and optimally place the hip implant to the plan.

As of December 31, 2011, 49 MAKOplasty® THA applications have been sold in the U.S.; hospitals in California, New York, and Florida are among many locations nationwide now offering MAKOplasty® THA.

More information about MAKOplasty® can be found at http://makoplasty.com.

About MAKO Surgical Corp.

MAKO Surgical Corp. is a medical device company that markets its RIO® Robotic-Arm Interactive Orthopedic system, joint specific applications for the knee and hip, and proprietary RESTORIS® implants for orthopedic procedures called MAKOplasty®. The RIO is a surgeon-interactive tactile surgical platform that incorporates a robotic arm and patient-specific visualization technology, which enables precise, consistently reproducible bone resection for the accurate insertion and alignment of MAKO's RESTORIS implants. The MAKOplasty solution incorporates technologies enabled by an intellectual property portfolio including more than 300 U.S. and foreign, owned and licensed, patents and patent applications. Additional information can be found at www.makosurgical.com.

Комментариев нет: